Billy Wynne J.D.

Founder & Chairman

A.B., Dartmouth College; J.D., University of Virginia
(202) 309-0796
billy@wynnehealth.com

Billy Wynne is a nationally respected strategic advisor to elite health care organizations, including Fortune 500 companies, marquee health systems, and prominent foundations. After building one of Washington’s largest health policy practice, he and his team established the Wynne Health Group in January 2018.

Prior to his private sector career, Mr. Wynne served as Health Policy Counsel to the Senate Finance Committee where he was a key drafter and negotiator of several health care laws and assisted in the development of the health care reform “White Papers” that served as the basis for the Affordable Care Act. He has published several dozen articles in Health Affairs and other platforms, often appears on cable news, and is frequently cited by the New York Times, Washington Post, Politico, and other publications.

Mr. Wynne is also a social entrepreneur, having founded Policy Hub, the only comprehensive aggregator of federal health policy analysis, the Public Option Institute, which is dedicated to providing clear analysis of public option programs and recommending best practices, and Awake, Colorado’s first alcohol-free bar and spirit store.

Mr. Wynne received a bachelor’s degree in Government from Dartmouth College and a law degree from the University of Virginia. He is a member of the District of Columbia and Virginia bar associations and has served on several boards, including Operation Smile, Chinese Children Adoption International, and the Zen Center of Denver.

When he’s not working in Washington, Mr. Wynne lives in Denver, CO with his wife, Christy, and their children, Eleanor and Lei.

E&C Health Members Discuss Aduhelm, Pandemics, Rare Diseases in FDA User Fee Reauthorization Hearing

On Feb. 3, 2022, the Subcommittee on Health of the House Committee on Energy & Commerce (E&C) convened a hearing on the reauthorization of three Food and Drug Administration (FDA) user fee programs (hearing memo). These include the seventh reauthorization of the Prescription Drug User Fee Act (PDUFA VII), the third reauthorization of the Generic…

Read More...

Health Policy Fellow: Federal Government Relations & Policy (Part-time; Stipend)

Wynne Health Group – a mission-driven, public interest health policy consulting and advocacy firm – seeks applicants with a strong interest in federal health policy and politics to join our DC team as a Fellow. This opportunity is ripe for students looking to gain first-hand experience working with lobbyists and consultants on key legislative and…

Read More...

Welcome to the WynneSights Blog

Welcome to the new WynneSights Blog. Soon we will be posting original commentary on the most important issues driving the health policy debate in Washington and across the country. Feel free to contact us if you have any ideas for topics or would like to post a guest blog. Thank you very much for visiting…

Read More...